Claro Advisors LLC Acquires 162 Shares of The Clorox Company (NYSE:CLX)

Claro Advisors LLC grew its holdings in The Clorox Company (NYSE:CLX) by 2.5% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,599 shares of the company’s stock after acquiring an additional 162 shares during the quarter. Claro Advisors LLC’s holdings in Clorox were worth $1,075,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Insight Folios Inc boosted its position in shares of Clorox by 3.0% in the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock valued at $358,000 after acquiring an additional 63 shares during the period. Fiduciary Group LLC lifted its position in Clorox by 0.4% during the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock worth $2,600,000 after purchasing an additional 72 shares during the period. GHP Investment Advisors Inc. lifted its position in Clorox by 2.0% during the second quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock worth $496,000 after purchasing an additional 72 shares during the period. SPC Financial Inc. lifted its position in Clorox by 2.2% during the second quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock worth $476,000 after purchasing an additional 75 shares during the period. Finally, Massmutual Trust Co. FSB ADV lifted its position in Clorox by 17.2% during the third quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $83,000 after purchasing an additional 75 shares during the period. Institutional investors own 78.53% of the company’s stock.

Insiders Place Their Bets

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.57% of the company’s stock.

Clorox Stock Performance

Shares of CLX stock opened at $167.64 on Monday. The stock has a market capitalization of $20.75 billion, a PE ratio of 58.41, a PEG ratio of 3.10 and a beta of 0.41. The Clorox Company has a one year low of $127.60 and a one year high of $169.09. The business’s 50 day simple moving average is $162.45 and its 200 day simple moving average is $147.52. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.49 EPS. As a group, research analysts forecast that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd were issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.91%. The ex-dividend date was Wednesday, October 23rd. Clorox’s payout ratio is 170.03%.

Analyst Ratings Changes

CLX has been the subject of several recent analyst reports. Evercore ISI cut their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and upped their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Deutsche Bank Aktiengesellschaft boosted their target price on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Finally, Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and boosted their target price for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Five research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $155.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.